2.670
+0.070
+(2.69%)
At close: April 17 at 4:08:07 PM GMT+8
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | 1 | 2 |
Avg. Estimate | -- | -- | 152.07M | 423.51M |
Low Estimate | -- | -- | 152.07M | 397.69M |
High Estimate | -- | -- | 152.07M | 449.33M |
Year Ago Sales | -- | -- | 91.95M | 152.07M |
Sales Growth (year/est) | -- | -- | 65.38% | 178.50% |
EPS Trend
Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
6996.HK | -- | -- | -- | -- |
S&P 500 | 6.92% | 5.09% | 8.78% | 14.15% |
Related Tickers
2142.HK HBM Holdings Limited
7.180
0.00%
6998.HK Genor Biopharma Holdings Limited
2.060
-1.90%
6990.HK Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
285.400
-1.25%
1672.HK ASCLETIS-B
4.940
-4.63%
TLPPF Telix Pharmaceuticals Limited
16.46
0.00%
NAUT Nautilus Biotechnology, Inc.
0.7580
+4.80%
NAMS NewAmsterdam Pharma Company N.V.
16.34
+1.93%
OLMA Olema Pharmaceuticals, Inc.
4.4200
+3.76%
9926.HK Akeso, Inc.
82.950
-0.90%
MGNX MacroGenics, Inc.
1.2600
+6.78%